New antigens for the serological diagnosis of human visceral leishmaniasis identified by immunogenomic screening.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Early Diagnosis*; Antigens, Protozoan/*blood ; Leishmania infantum/*isolation & purification ; Leishmaniasis, Visceral/*blood; Animals ; Antigens, Protozoan/immunology ; Brazil ; Chagas Disease/blood ; Chagas Disease/immunology ; Chagas Disease/parasitology ; Cross Reactions ; Diagnostic Tests, Routine ; Dog Diseases/blood ; Dog Diseases/epidemiology ; Dog Diseases/parasitology ; Dogs ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunogenetics/methods ; Leishmania infantum/immunology ; Leishmania infantum/pathogenicity ; Leishmaniasis, Visceral/immunology ; Leishmaniasis, Visceral/parasitology ; Serologic Tests

Visceral leishmaniasis (VL) still represents a serious public health problem in Brazil due to the inefficiency of the control measures currently employed, that included early diagnosis and treatment of human cases, vector control, euthanasia of infected dogs and, recently approved in Brazil, treatment with Milteforam drug. Effective clinical management depend largely on early and unequivocal diagnosis, however, cross-reactivity have also been described in serological tests, especially when it refers to individuals from areas where Chagas' disease is also present. Thus, to discover new antigens to improve the current serological tests for VL diagnosis is urgently needed. Here, we performed an immunogenomic screen strategy to identify conserved linear B-cell epitopes in the predicted L. infantum proteome using the following criteria: i) proteins expressed in the stages found in the vertebrate host, amastigote stage, and secreted/excreted, to guarantee greater exposure to the immune system; ii) divergent from proteins present in other infectious disease pathogens with incidence in endemic areas for VL, as T. cruzi; iii) highly antigenic to humans with different genetic backgrounds, independently of the clinical stage of the disease; iv) stable and adaptable to quality-control tests to guarantee reproducibility; v) using statistical analysis to determine a suitable sample size to evaluate accuracy of diagnostic tests established by receiver operating characteristic strategy. We selected six predicted linear B-cell epitopes from three proteins of L. infantum parasite. The results demonstrated that a mixture of peptides (Mix IV: peptides 3+6) were able to identify VL cases and simultaneously able to discriminate infections caused by T. cruzi parasite with high accuracy (100.00%) and perfect agreement (Kappa index = 1.000) with direct methods performed by laboratories in Brazil. The results also demonstrated that peptide-6, Mix III (peptides 2+6) and I (peptides 2+3+6) are potential antigens able to used in VL diagnosis, represented by high accuracy (Ac = 99.52%, 99.52% and 98.56%, respectively). This study represents an interesting strategy for discovery new antigens applied to serologic diagnosis which will contribute to the improvement of the diagnosis of VL and, consequently, may help in the prevention, control and treatment of the disease in endemic areas of Brazil.
Competing Interests: The authors have declared that no competing interests exist.

PLoS Negl Trop Dis. 2017 May 30;11(5):e0005562. (PMID: 28557986)
Parasitol Today. 1992 May;8(5):174-7. (PMID: 15463609)
J Clin Microbiol. 2017 Feb;55(2):495-503. (PMID: 27927927)
Immunome Res. 2006 Apr 24;2:2. (PMID: 16635264)
Nat Methods. 2011 Sep 29;8(10):785-6. (PMID: 21959131)
Appl Microbiol Biotechnol. 2018 Jul;102(14):6069-6080. (PMID: 29736822)
Appl Microbiol Biotechnol. 2015 Feb;99(3):1323-36. (PMID: 25359475)
Bioinformatics. 2005 Aug 15;21(16):3433-4. (PMID: 15955779)
PLoS One. 2012;7(5):e35671. (PMID: 22693548)
Br J Radiol. 2005 Feb;78(926):158-60. (PMID: 15681330)
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):299-302. (PMID: 16460490)
Rev Esp Enferm Dig. 2009 Jun;101(6):439-40. (PMID: 19630469)
PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004349. (PMID: 26937644)
Trans R Soc Trop Med Hyg. 2002 Jan-Feb;96(1):21-8. (PMID: 11925984)
Acta Trop. 2009 Sep;111(3):289-94. (PMID: 19467216)
Trop Med Int Health. 2001 Feb;6(2):108-13. (PMID: 11251906)
Parasitol Res. 2016 Apr;115(4):1649-58. (PMID: 26782811)
Science. 2005 Jul 15;309(5733):409-15. (PMID: 16020725)
Acta Trop. 2014 Sep;137:25-30. (PMID: 24801885)
Radiology. 1983 Sep;148(3):839-43. (PMID: 6878708)
Biomed Res Int. 2015;2015:401509. (PMID: 25710003)
Med Microbiol Immunol. 2001 Nov;190(1-2):3-8. (PMID: 11770105)
Am J Trop Med Hyg. 2007 Dec;77(6):1051-3. (PMID: 18165520)
Nucleic Acids Res. 2010 Jan;38(Database issue):D457-62. (PMID: 19843604)
J Health Popul Nutr. 2010 Jun;28(3):281-5. (PMID: 20635639)
Nat Rev Microbiol. 2004 Mar;2(3):231-40. (PMID: 15083158)
Clin Vaccine Immunol. 2015 Nov;22(11):1187-96. (PMID: 26376929)
Nucleic Acids Res. 2014 Jan;42(Database issue):D756-63. (PMID: 24259432)
Nat Genet. 2007 Jul;39(7):839-47. (PMID: 17572675)
Curr Protein Pept Sci. 2015;16(8):782-90. (PMID: 25961398)
Parasitol Int. 2018 Jun;67(3):344-350. (PMID: 29408435)
Diagn Microbiol Infect Dis. 2017 Mar;87(3):219-225. (PMID: 27939286)
Parasit Vectors. 2015 Feb 28;8:133. (PMID: 25889286)
Am J Trop Med Hyg. 1987 Sep;37(2):271-6. (PMID: 3310684)
Vet Parasitol. 2016 Feb 15;217:81-8. (PMID: 26827866)
Vet Parasitol. 2016 Jun 15;223:115-9. (PMID: 27198787)
Clin Vaccine Immunol. 2014 Jan;21(1):96-106. (PMID: 24256622)
J Proteomics. 2017 Jan 16;151:174-181. (PMID: 27262223)
Clin Vaccine Immunol. 2007 Aug;14(8):1045-9. (PMID: 17522327)
PLoS Negl Trop Dis. 2011 Sep;5(9):e1310. (PMID: 21931874)
PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3429. (PMID: 25569685)
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18. (PMID: 15225981)
Nat Rev Microbiol. 2004 Sep;2(9):692. (PMID: 15378809)
Stat Med. 1997 Jul 15;16(13):1529-42. (PMID: 9249923)
Bull World Health Organ. 1990;68(1):39-43. (PMID: 2189584)
Zoonoses Public Health. 2009 Feb;56(1):41-8. (PMID: 18990196)
PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2524. (PMID: 24205430)
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W20-5. (PMID: 15215342)
J Proteome Res. 2011 May 6;10(5):2172-84. (PMID: 21355625)
Diagn Microbiol Infect Dis. 2018 Nov;92(3):196-203. (PMID: 29941364)
Trans R Soc Trop Med Hyg. 1988;82(1):66-8. (PMID: 3176153)
J Mol Biol. 1990 Oct 5;215(3):403-10. (PMID: 2231712)
Cell Immunol. 2018 Jan;323:59-69. (PMID: 29128045)
Clin Infect Dis. 1997 Apr;24(4):684-703. (PMID: 9145744)

0 (Antigens, Protozoan)

Date Created: 20181221 Date Completed: 20190517 Latest Revision: 20200309

20240105

PMC6301785

10.1371/journal.pone.0209599

30571783